Abstract In the present study, we evaluated the effect of neutrophil elastase inhibitor, sivelestat sodium hydrate on ischemia-reperfusion injury in the rat bladder. Rat abdominal aorta was clamping with a small clip to induce ischemia-reperfusion injury in the bladder. Eight-week-old male Sprague Dawley rats were divided into four groups; sham-operated control rats, 30 min ischemia-60 min reperfusion (IR) rats, and IR rats treated with 15 or 60 mg/ kg of sivelestat sodium hydrate. Sixty minutes prior to induction of ischemia, sivelestat sodium hydrate was administrated intraperitoneally. Real-time monitoring of blood flow and nitric oxide (NO) release were measured simultaneously with a laser Doppler flowmeter and an NO-selective electrode, respectively. The NO 2 -NO 3 and malonaldehyde (MDA) concentrations were measured in the experimental urinary bladders. Clamping of the abdominal aorta, blood flow was rapidly decreased and NO release was gradually increased. After removing the clip, blood flow was rapidly increased and NO release was gradually returned to the basal level. These movements of blood flow and NO release were inhibited by treatment with sivelestat sodium hydrate in a dose-dependent manner. Both NO 2 -NO 3 and MDA concentrations in the bladder were increased by induction of IR, and NO 2 -NO 3 and MDA concentrations were decreased by treatment with high dose of sivelestat sodium hydrate significantly. Our data indicated that sivelestat sodium hydrate could inhibit increasing NO 2 -NO 3 and MDA concentrations by IR, and it has potentiality protective effects on IR injury in the rat urinary bladder.
Introduction
Ischemia and subsequent reperfusion of the urinary bladder are associated with various age-related disorders, such as acute and/or chronic urinary retention caused by benign prostatic enlargement, atherosclerosis, vasospasm, embolization, thrombosis, and ligation of arteries during pelvic operations [1] [2] [3] . Furthermore, during voiding against an obstruction, the resulting increase in intravesical pressure in the bladder causes occlusion of detrusor blood vessels and a reduction in blood flow and oxygen tension. After voiding, this pressure in the detrusor is decreased, and subsequently reperfusion is occurred in the bladder. Prolonged acute and chronic overdistension can result in injury to the neural pathways responsible for micturition, reduce bladder elasticity, alter the biochemical and neuronal responsiveness of the bladder, and subsequently lead to micturition problems [4, 5] . Ischemia-reperfusion (IR) injury causes dysfunction of the urinary bladder, which results in instability and impairment of detrusor contractility during urination [6] . Previously we reported that, after overdistension, catheterization/decompression induces reperfusion injury in the bladder, and that reactive oxygen species are one of the main contributing factors in this injury [7] . Experimentally we have reported that ischemia and subsequent reperfusion significantly damage the bladder function [8] [9] [10] Polymorphonuclear neutrophils (PMNs) play an important role in the development of IR injury [11] . PMNs are mediators of microcirculatory endothelial injury in many acute pathological conditions [12] . PMNs have also been shown to produce active oxygen derivatives. It is also known that activated neutrophils can cause tissue injury by releasing cytotoxic oxygen free radicals and some proteases. Peroxidation of phospholipid fatty acid is generally recognized as one of the most important mechanisms through which active oxygen free radicals induce cellular damage [13, 14] . There are increasing evidences suggesting that PMNs are a causal factor in the development of IR injury by inducing oxygen free radicals and proteases, and subsequent lipid peroxidation [11, 15] . Several reports have shown that a potent neutrophil elastase inhibitor, sivelestat sodium hydrate, protects against IR injury on the lung, liver, small intestine, renal, and transplanted organs [16] [17] [18] [19] [20] . Although the mechanisms of sivelestat sodium hydrate on IR injury are complicated, the main mechanism is considered that sivelestat sodium hydrate selectively and competitively inhibits the release of neutrophil elastase [20] .
We hypothesized that neutrophil elastase inhibitors can prevent IR injury in the bladder. There is, however, no information available regarding to neutrophil elastase inhibitors and IR injury in the urinary bladder. In order to clarify the effect of a neurtrophil elastase inhibitor, sivelestat sodium hydrate in IR in the bladder, we attempted to investigate roles of the neurtrophil elastase inhibitor on IR injury in the rat bladder.
Materials and methods

Animal model
All animal experiments were performed in accordance with the guidelines set by the Tottori university committee for Animal Experimentation. Male Sprague Dawley rats, 8 weeks old and weighing 250-320 g (SLC, Shizuoka, Japan), were divided into four groups; sham operated control (Cont), ischemia (30 min)-reperfusion (60 min) (IR) and ischemia (30 min)-reperfusion (60 min) rats treated with sivelestat sodium hydrate 15 mg/kg or 60 mg/ kg groups (IR + low-ONO and IR + high-ONO, respectively) (N = 5-8 in each group). Sixty minutes prior to the induction of ischemia, sivelestat sodium hydrate was administrated intraperitoneally. The protocol of this study was shown in Fig. 1 . The ischemic condition was conducted according to previous reports [8, 9] . Briefly, under pentobarbital anesthesia (50 mg/kg, i.p.), the abdominal aorta was clamped just above its bifurcation with a small clip (Sugita standard aneurysm clip, holding force 145 g; Mizuho Ikakogyo, Tokyo) for 30 min in the IR, IR + low-ONO and IR + high-ONO groups to induce ischemic condition. Then, the clip was removed to expose 60 min of reperfusion in IR, IR + low-ONO and IR + high-ONO rats.
In vivo real-time monitoring of blood flow and nitric oxide (NO) release in rat bladder Real-time monitoring of blood flow and NO release were measured simultaneously with a laser Doppler flowmeter and an NO-selective electrode, respectively. Blood flow in the rat bladder was measured with a laser Doppler flowmeter (BRL-100; Bioresearch Co., Nagoya) as previously reported [9, 21] . Briefly, under pentobarbital anesthesia, the probe was put into the bladder smooth muscle, and blood flow in the bladder was measured before, during, and after ischemia in the IR, IR + low-ONO and IR + high ONO groups. Blood flow is expressed as a percentage of the basal level.
Real-time monitoring of NO release in the rat bladder dome was conducted in the IR, IR + low-ONO and IR + high-ONO groups as previously reported [9, 21] . In brief, an NO-selective electrode (NOE-47, tip diameter of 0.2 mm; Inter Medical Co., Nagoya) was inserted into the smooth muscle of the rat bladder dome from the serosal side and the tip of the electrode was fixed in the smooth muscle. A reference electrode was placed in the subcutaneous tissue. NO release was measured with an NO-monitor (model NO-501; Inter Medical Co., Nagoya) and expressed in terms of current in picoamperes (pA). NO release during IR was express as a percentage of the basal level.
Measurement of NO 2 -NO 3 concentrations in the bladder NO 2 -NO 3 concentrations in the bladder were measured by means of the Griess method according to our previous report [21] . In short, the tissues were homogenized with the Multibeads Shocker Ò (YASUIKIKI, Osaka, Japan) and centrifuged at 10,000g for 20 min. The supernatant solutions were recentrifuged at 100,000g for 30 min. Then the supernatant solutions were used to perform the NO 2 -NO 3 assay. [22] .
Measurement of malonaldehyde (MDA) concentrations in the bladder
In order to investigate lipid peroxidation of the bladder during IR, MDA, a marker of lipid peroxidation, concentrations were measured in the experimental rat bladder. The tissues were chopped into small pieces and the pieces were then homogenized in nine volumes of PBS buffer in 5 mM butylated hydroxytoluene with five 10-second bursts using the Multi-beads Shocker (YASUIKIKI, Osaka, Japan) with the speed set at 1,800 rpm. Then the MDA concentrations in the bladder were measured by colorimetric assay according to the manufacture's instructions (BIOXYTEC MDA-586 TM kits, OXIS International, Portland, OR). The absorbance was measured at 586 nm. The values were estimated based on the amount of protein in the tissue. Protein was determined using a commercial kit (Protein Assay Rapid Kit wako , Wako Pure Chemical, Osaka, Japan) according to Watanabe and associates [22] .
Data analysis
A statistical comparison of the differences between groups was performed using analysis of variance and Fisher's multiple comparison tests. P \ 0.05 was regarded as the level of significance.
Drugs and chemicals
Sivelestat sodium hydrate was kindly gifted from Ono Pharmaceutical Co., Ltd., (Osaka, Japan). All other chemicals were of reagent grade.
Result
Measurement of blood flow during ischemiareperfusion in the bladder Figure 2 (upper panel) shows the blood flow during IR in the rat bladder. Clamping of the rat abdominal aorta decreased blood flow to less than 15% of the basal level measured before clamping. After removal of the clip, the blood flow rapidly recovered to the basal level within 1 min in all groups. Treatment with the low dose of sivelestat sodium hydrate tended to decrease the blood flow in the bladder during reperfusion phase compared to the IR group. The blood flow of the bladder in the IR + high-ONO group was significantly lower than that of IR group during reperfusion phase. These data suggest that treatment with the high dose of sivelestat sodium hydrate significantly decreased blood flow during not ischemic phase but reperfusion phase.
In vivo NO release during ischemia-reperfusion in the bladder
Levels of NO released in the rat bladder before, during, and after the induction of ischemia are shown in Fig. 2 panel). Immediately following clipping of the abdominal aorta, NO release rapidly increased, and reaching a plateau within approximately 30 min in the IR group. When an NO electrode was inserted into rat bladder treated with both doses of sivelestat sodium hydrate, NO release was decreased in a dose-dependent manner. The NO release during IR was inhibited slightly in the IR + low-ONO group, and significantly in the IR + high-ONO group in the experimental rat bladder. These data suggest that treatment with sivelestat sodium hydrate inhibited NO release during IR in the bladder.
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NO 2 -NO 3 concentrations in the bladder
The data of NO 2 -NO 3 concentrations in the bladder are shown in the Table 1 . The NO 2 -NO 3 concentrations in the bladder of IR group were significantly higher than those of Cont group. Treatment with the low dose of sivelestat sodium hydrate tended to decrease in NO 2 -NO 3 concentrations in the bladder compared to those of IR group. Treatment with the high dose of sivelestat sodium hydrate significantly decreased NO 2 -NO 3 concentrations in the bladder. These data support the data of real-time monitoring of NO release during IR in the bladder.
MDA concentrations in the bladder
The tissue concentrations of MDA are also show in Table 1 . The MDA concentrations in the bladder in the IR group were significantly higher than those in the control group. Treatment with the low dose of sivelestat sodium hydrate tended to decrease the MDA concentrations in the bladder compared to the IR group. However, treatment with high dose of sivelestat sodium hydrate significantly decreased the MDA concentrations in the bladder compared to those in the IR group. Our data indicate that treatment with sivelestat sodium hydrate decreased MDA concentrations in the bladder during IR.
Discussion
In the present study, we demonstrated preventive effects of sivelestat sodium hydrate on IR injury in the rat bladder. In this study, we showed that bladder dysfunction and lipid peroxidation in the bladder were caused by IR in the bladder, and this injury could be prevented by treatment with sivelestat sodium hydrate.
Human neutrophil elastase is a protease capable of hydrolyzing most connective tissue components. It has been suggested to participate in the tissue injury of rheumatoid arthritis [23] , acute respiratory distress syndrome [24] , emphysema [25] and septic shock [26] . Although plasma and interstitial fluid contain powerful anti-proteinases such as a1-proteinase inhibitor (a1-PI) and a2-macroglobulin (a2-MG), their elastase inhibitory activities have been suggested to be circumvented because a1-PI and a2-MG, macromolecular inhibitors, are excluded from close contacts between neutrophils and substrate [27, 28] . In contrast to these anti-proteinases, a low molecular weight human neutrophil elastase inhibitor might be delivered to achieve close contact [29] , suggesting the advantage of a low molecular weight human neutrophil elastase inhibitor as a therapeutic agent.
In this present study, we measured simultaneously both blood flow and NO release during IR in the bladder. In the real-time monitoring of blood flow, we showed that blood flow levels during reperfusion phase were significantly smaller when treated with the high dose of sivelestat sodium hydrate than without treatment. We also measured the NO release during IR in the bladder. Clamping of the abdominal aorta induced a gradual increase in NO release, and removing the clip induced a gradual decrease in NO release in the bladder. Treatment with sivelestat sodium hydrate inhibited the NO release in the bladder in a dosedependent manner. We previously reported that NO-NOS system regulates blood flow in the bladder and testis [9, 21] . In the present study, decreases in NO occur within 5 min. Previously we reported that IR increased NO production in the bladder, and that the main contributing subtype of NOS was eNOS in the bladder [9] . Interestingly, sivelestat sodium hydrate is reported to inhibit the activity of inducible NO synthase (iNOS). Toda et al. used a rat model of hemorrhagic shock followed by resuscitation (HSR) in the lung treated with or without the neutrophil elastase inhibitor, sivelestat sodium hydrate. Treatment with sivelestat sodium hydrate markedly decreased both TNF-a m-RNA and iNOS gene expression levels than those of HSR rat without sivelestat sodium hydrate treatment group [30] . Taken together, it may be explained that inhibition of eNOS and possibly iNOS activities caused by sivelestat sodium hydrate leads to inhibition of NOmediated vasodilation and subsequently to reduce the blood flow in the reperfusion phase in the bladder. The neutrophil elastase has been implicated as playing an important role on IR injury by releasing toxic mediators such as oxygen free radicals. Neutrophil elastase decomposes peptides in extracellular matrix. The protease also has many effects such as chemotactic, complement activation, and inducing gene expression of various cytokines, growth factors, and endothelin [16] . These oxygen free radicals initiate a chain reaction that leads to damage of the cell membrane by lipid peroxidation [14] . This irreversible process occurs primarily by the peroxidation of unsaturated fatty acids that are essential parts of the cell membrane. The extent of lipid peroxidation can be evaluated by measuring tissue MDA levels. During IR or inflammation, PMNs accumulated and reactivated to produce leukocyte endothelial interaction, emigration, and subsequent tissue damage. Activated and accumulated leukocytes produce a second burst of oxygen radicals, along with other neutrophil-derived products, which cause further and maybe more severe damage [14] . Phagocytes such as neutrophils and macrophages, and the inflammatory chemical mediators constitute a complex cascade and leading to remote organ injury [31] . Neutrophil elastase decomposes peptides in extracellular matrix. The protease also has many effects such as chemotactic, complement activation, and inducing gene expression of various cytokines [32] . In the present study, the MDA concentrations in the bladder were significantly increased in the IR group than those in the Cont group. Treatment with sivelestat sodium hydrate significantly decreased MDA production caused by IR, and interestingly, the MDA concentrations in the high dose of sivelestat sodium hydrate group were significantly lower than those in the IR group. Our present data indicated that bladder dysfunction and lipid peroxidation in the bladder are caused by IR in the bladder, and that this injury can be prevented by treatment with sivelestat sodium hydrate. As for this, neutrophil elastase inhibitor is protective by a direct action as a protease damaged for tissue, and activated and accumulated leukocytes produce a second burst of oxygen radicals and the cytokine. However, it is thought that further examination is necessary to prove this phenomenon.
Conclusions
In the present study, the MDA and NO 2 -NO 3 concentrations in the bladder were significantly increased in the IR group compared to those in the Cont group. Treatment with sivelestat sodium hydrate significantly decreased the MDA and NO 2 -NO 3 productions caused by IR. Our data indicated that sivelestat sodium hydrate has potentiality protective effects on IR injury damage in the rat urinary bladder.
